{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-151254","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.119731+00:00","generated_at":"2026-05-18T15:55:12.774014+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Revolution Medicines stockholders elect four Class II directors, ratify PwC, approve say-on-pay at 2025 annual meeting","bullets":["Directors elected: Frank Clyburn, Sandra Horning, Sushil Patel, Thilo Schroeder; each received >119M votes for.","Ratified PricewaterhouseCoopers as independent auditor for FY2025 with 157.9M votes for, 215K against.","Advisory say-on-pay approved with 145.3M votes for, 2.6M against, 10.2M broker non-votes.","Record date April 28, 2025; 186.3M shares outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-151254","json":"https://secwatch.observer/filing/0001193125-25-151254.json","markdown":"https://secwatch.observer/filing/0001193125-25-151254.md","text":"https://secwatch.observer/filing/0001193125-25-151254.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525151254/0001193125-25-151254-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312525151254/d12458d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T15:55:12.774014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}